Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan

Robyn J. Barst, David Langleben, David Badesch, Adaani Frost, E. Clinton Lawrence, Shelley Shapiro, Robert Naeije, Nazzareno Galie

Research output: Contribution to journalArticlepeer-review

453 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases